NAXYN 250 MG

Country: Iżrael

Lingwa: Ingliż

Sors: Ministry of Health

Ingredjent attiv:

NAPROXEN 250 MG

Disponibbli minn:

TEVA PHARMACEUTICAL INDUST.LTD

Kodiċi ATC:

M01AE02

Għamla farmaċewtika:

TABLETS

Rotta amministrattiva:

PER OS

Manifatturat minn:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Grupp terapewtiku:

NAPROXEN

Indikazzjonijiet terapewtiċi:

- Relief of the signs and symptoms of rheumatic diseases including osteoarthritis, ankylosing spondylitis of rheumatoid arthritis, both in the treatment of acute flares and in the long-term management of the disease. - Juvenile Rheumatoid Arthritis. - Periarticular and Musculoskeletal Disorders.- Relief of pain in bursitis, tendinitis, synovitis, tenosynovitis and lumbago. - Relief of pain, swelling, tenderness and fever in acute gouty arthritis. - Relief of symptoms of primary dysmenorrhea.

Data ta 'l-awtorizzazzjoni:

2009-05-01